Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Recognize Polish academic titles as proof of language proficiency for foreign-trained doctors.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Eating grape powder may reduce the severity of skin allergy symptoms.

Aortic aneurysm treatment has shifted to less invasive methods, improving safety and outcomes.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

ITK inhibitors may effectively treat alopecia areata.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Aging reduces skin cell renewal and defense against germs due to TGFbeta, but blocking TGFbeta could help restore these functions.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Some hair loss drugs can cause a unique type of hair loss that resembles both psoriasis and alopecia.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Upadacitinib improved multiple immune-related conditions in one patient.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Baricitinib reduces inflammation and improves cell health in premature aging cells.